Biomedix has developed a unique PADnet patient-facing video for our customers! Designed to help providers educate patients about Peripheral Artery Disease and the PADnet test, this video is ideal for healthcare practices to play in waiting rooms, show to patients prior to a PADnet test, and use in any other Read more…
Twin Cities, MN— October 5th, 2023 — Biomedix, a market-leading medical technology and innovation company, was invited to screen congressional representatives and their staff at the United States Capitol with PADnet Xpress during the PAD Caucus briefing on September 27th, 2023. PAD Caucus Co-Chairs, Congressman Donald Payne, Jr. and Congressman Read more…
Have Additional Questions About PVD And The HCC v28 Model? Fill Out The Form Below To Schedule A Consultation Notice: JavaScript is required for this content. A new version (v28) of the CMS HCC risk adjustment model was finalized earlier this year. The new v28 model includes changes in the Read more…
Cigarette smoking has long been considered to be a major risk factor for Peripheral Artery Disease (PAD). However, there is less research on whether or not the use of noncombustible tobacco is associated with an elevated risk of vascular disease. A recent study was published in the American Journal of Read more…
Peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI) are serious complications of diabetes that can significantly impact a person’s quality of life. A recent study published in Vascular Medicine examines the association between these conditions and socioeconomic deprivation in people with diabetes. The study involved a population data-linkage and Read more…
FDA Clearance For PADnet Xpress For Home Use Twin Cities, MN— November 30th, 2022 — Biomedix, a market-leading medical technology and innovation company, announced that the PADnet Xpress device has received clearance from the FDA for use in the home. “We are excited to announce the expanded clearance for in-home use of Read more…
A new study found that walking at a pace that induces pain or discomfort is better at improving walking availability for people with Peripheral Artery Disease (PAD). The study covered 264 people with PAD, with participants from four U.S medical centers. Designed to examine the effects of a home-based walking exercise program, Read more…
At the latest International Symposium on Endovascular Therapy (ISET) show, PADnet Xpress was featured in a medical poster that MIMIT Healthcare submitted, highlighting the clinical value of a population health screening for PAD in a Specialized Nursing Facility (SNF), and the combined clinical accuracy, speed, and ease-of-use of PADnet Xpress. Read more…
New study on PAD and claudication A recent study published in Endovascular Today examined patients experiencing symptomatic peripheral artery disease (PAD) and other associated adverse medical events such as amputations and myocardial infarction. The authors noted that only 20% – 30% of patients with PAD present with the classic symptom Read more…
A new study which was published in the Journal of the American Heart Association, found that obese people had a higher prevalence of Peripheral Artery Disease (PAD). Although the American Heart Association has released scientific statements describing obesity as an independent risk factor for CVD (cardiovascular disease), including CHD (coronary Read more…